Brief: MiMedx Q2 Sales USD 87.207 Million Vs. IBES Estimate USD 88.9 Million
Jul 31 (Reuters) - MiMedx Q2 operating income USD 23.45 million. * Q2 gross profit USD 72.352 million * Q2 net income USD 17.625 million
Recent news on MiMedx
See all newsBrief: Mimedx Announces Favorable Federal Court Ruling In Axiofill® Regulatory Classification Matter
MiMedx Group Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: Mimedx To Acquire Sanara Medtech
MiMedx Q2 sales fall less than expected; set to acquire Sanara MedTech
Brief: MiMedx Q2 Sales USD 64.362 Million Vs. IBES Estimate USD 63.5 Million